Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

JOHNSON & JOHNSON

(JNJ)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Sector news Other Pharmaceuticals
03:56pPFIZER SHOT REPORTEDLY OFFERS PARTIA : Bloomberg
MT
03:56pOmicron Can Partially Evade Vaccines Protection, According to South African Lab Tests
DJ
10:37aLegend Biotech Submits New Drug Application for Myeloma CAR-T Therapy to Japanese Regul..
MT
08:37aRecursion Pharmaceuticals Sets Drug-Discovery Pact With Roche, Genentech
DJ
07:16aEU agencies endorse mix-and-match of COVID-19 vaccines
RE
06:49aNOVO NORDISK : Deutsche Bank reaffirms its Buy rating
MD
06:22aEU Authorizes Roche's Arthritis Medicine for Treatment of Severe COVID-19
MT
05:34aNew York City to Impose Vaccine Mandate on Private Sector Companies
MT
04:36aEU Approves Roche's Actemra/RoActemra Against Severe Covid-19
DJ
01:59aROCHE HOLDINGS AG : Jefferies keeps its Buy rating
MD
01:58aNOVO NORDISK : Jefferies reiterates its Sell rating
MD
01:27aRoche Rolls Out AI-Based Algorithms to Evaluate Breast Cancer Markers
MT
12/06Fitch Holds Roche's Rating on Strong Financial Profile; Outlook Stable
MT
12/06AstraZeneca, Pfizer-BioNTech's COVID-19 Jabs Work Well With Moderna Shot, UK Study Says
MT
12/06Roche Wraps Up Share Repurchase Deal With Novartis, Affirms FY21 Outlook
MT
12/06Mixing Pfizer, AstraZ COVID-19 shots with Moderna gives better immune response -UK stud..
RE
12/06INSIDER SELL : Pfizer
MT
12/06Wall Street regains some ground with help from easing virus fears
RE
12/06Wall Street closes up as easing in virus fears aids rebound
RE
12/06COVID-19 Reopening Plays Among Top Gainers While Vaccine Makers Tumble on Reports Omicr..
MT
12/06EU regulator backs Roche's arthritis drug for treating severe COVID-19
RE
12/06Biohaven's migraine therapy shows rapid pain relief in late-stage study
RE
12/06European Medicines Agency To Expand Marketing Authorization For Roche's Medicine To Tre..
MT
12/06EU regulator backs extending RoActemra use for adults with severe COVID-19
RE
12/06Legend Biotech Submits New Drug Application for Myeloma Therapy to Japanese Regulator
MT
12/06EMA Recommends Approval For Use Of RoActemra In Adults With Severe COVID-19
RE
12/06Kaleido Biosciences Expands and Extends Collaboration With Janssen
MT
12/06Biohaven's migraine therapy shows rapid pain relief in late-stage study
RE
12/06Roche to Roll Out COVID-19, Flu Rapid Antigen Test in 2022
MT
12/06COVID shots are finally arriving, but Africa can't get them all into arms
RE
12/06Merck & Co. Executive Says COVID-19 Pill's Safety Profile Remains 'Very Strong'
MT
12/05Pfizer Denies Claims of Funding Misinformation Against AstraZeneca's COVID-19 Jab
MT
12/05U.S. administers 470.3 mln doses of COVID-19 vaccines -CDC
RE
12/05Omicron variant found in nearly one-third of U.S. states
RE
12/04U.S. administers 468.5 mln doses of COVID-19 vaccines- CDC
RE
12/03Eli Lilly, AbCellera Land FDA's Expanded Emergency Use Approval for COVID-19 Antibody T..
MT
12/03Eli Lilly Gets FDA's Expanded Emergency Use Approval for Antibody Therapy to Treat COVI..
MT
12/03U.S. administers 466.3 mln doses of COVID-19 vaccines - CDC
RE
12/03FDA Expands Emergency Use for Lilly Antibody Combination for Covid-19 to Include Infant..
DJ
12/03Eli Lilly Sees FDA Granting EUA of Two Monoclonal Antibodies for Treatment of COVID in ..
MT
12/03AbCellera Biologics Names New Chief Commercial Officer
MT
12/03Canada Signs Deal for 1 Mln Doses of Pfizer Covid Antiviral and 500K Merck's Covid Pill
MT
12/03Vaccine makers could make Omicron-specific booster, says Fauci
RE
12/03Roche to Name New Member to Board of Directors, Re-Elect Chairman
DJ
12/03Roche Holding Ltd Announces Paul Bulcke Will Not to Stand for Re-Election to Its Board ..
CI
12/03European ADRs Move Sharply Lower in Friday Trading
MT
12/03BioNTech Capable of Quickly Modifying Vaccine for Omicron Variant, CEO Says
MT
12/03Eli Lilly, Innovent Biologics' Cancer Drug Added to China's Updated National Reimbursem..
MT
12/03BioNTech CEO Expects To Modify COVID-19 Vaccine To Omicron Variant
MT
12/03Drugmakers cut prices by 62% on average to get China state insurance listing
RE
1  2  3  4  5  6  7  8  9  10Next
Upcoming event on JOHNSON & JOHNSON